Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REGENERON PHARMACEUTICALS

(REGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about REGENERON PHARMACEUTICALS
12/06Goldman Sachs Starts Regeneron Pharmaceuticals at Buy With $824 Price Target
MT
12/06Regeneron to participate in h.c. wainwright and co. virtual event
AQ
12/03Regeneron to Participate in H.C. Wainwright & Co. Virtual Event
PR
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
12/02What COVID-19 vaccine and drug makers have to say about Omicron
RE
12/02MarketScreener's World Press Review - December 2, 2021
11/30Officials offer vaccine reassurance; WHO advises against travel bans
RE
11/30US Stocks Slump as Omicron Variant, Fed Chief's Comment on Faster Asset Purchase Taperi..
MT
11/30CLOSE UPDATE : US Stocks See Sharp Decline as Omicron Variant, Fed Chief Comment on Faster..
MT
11/30Yen, Swiss franc rally on global outlook risks after hawkish Powell
RE
11/30ANALYSIS : As Omicron plays havoc with markets, shares of vaccine makers surge
RE
11/30Wall St sinks as taper acceleration worries pile onto virus angst
RE
11/30Pharmaceutical Names to See Increased Volatility into Year End Amid Omicron Updates, Op..
MT
11/30Equities Drop Midday as Moderna CEO Questions COVID-19 Vaccines' Efficacy Against Omicr..
MT
11/30MIDDAY REPORT : US Stocks Drop as Moderna CEO Questions COVID-19 Vaccines' Efficacy Agains..
MT
11/30US Stocks Drop as Moderna CEO Warns on Efficacy of COVID-19 Vaccines Against Omicron; O..
MT
11/30Wall St drops over 1% on Powell's faster taper comments, Omicron worries
RE
11/30GLOBAL MARKETS LIVE : Amazon, Microsoft, Volvo, Glencore, Regeneron...
11/30TSX falls to one-month low on Omicron worries
RE
11/30Dow, S&P 500 slip as Omicron worries grow after vaccine warning
RE
11/30WALL STREET STOCK EXCHANGE : Questions about Omicron and vaccine efficiency rattle markets
11/30Regeneron Reportedly Says its Antibody Drug Could Be Less Effective Against Omicron Var..
MT
11/30Regeneron's COVID-19 antibody drug may be less effective against Omicron
RE
11/30Regeneron says COVID-19 drug could be less effective against Omicron variant
RE
11/30REGENERON PHARMACEUTICALS : Evaluating REGEN-COV® and Next Generation Antibodies against N..
PU
11/30Regeneron Pharmaceuticals, Confo Therapeutics to Collaborate on Antibody Discovery
MT
11/30Confo Therapeutics Enters into Collaborative Agreement with Regeneron Pharmaceuticals, ..
CI
11/26MarketScreener's World Press Review - November 26, 2021
11/26Merck's COVID-19 pill significantly less effective in new analysis
RE
11/23Nykode Therapeutics in Vaccine Deal With Regeneron Worth Up to $925 Million
DJ
11/23Nykode, Regeneron to Team Up On Cancer, Infectious Disease Vaccines
MT
11/23Nykode Therapeutics Enters into Collaboration Agreement with Regeneron to Develop Innov..
CI
11/23Vaccibody AS announced that it expects to receive NOK 178.305538 million in funding fro..
CI
11/22Regeneron Extends Research Collaboration With Decibel Therapeutics; Decibel Shares Rise..
MT
11/22Decibel Therapeutics, Inc. Announces Extension of Research Term Under Strategic Collabo..
CI
11/19BioNTech's Skin Cancer Vaccine Candidate Wins US FDA's Fast Track Status
MT
11/18WALL STREET STOCK EXCHANGE : Trading is the new online gambling
11/18INSIDER SELL : Regeneron Pharmaceuticals
MT
11/16Roche walks away from Atea partnership to develop COVID-19 pill
RE
11/16Regeneron Announces Investor Conference Presentations
PR
11/15Regeneron antibody cocktail approved by european commission to treat and prevent covid-..
AQ
11/15Regeneron announces $3 billion share repurchase program
AQ
11/15Regeneron Listed on Dow Jones Sustainability World Index for Third Consecutive Year
PR
11/12Regeneron Pharmaceuticals Board Approves $3 Billion Share Buyback Program
MT
11/12Regeneron Announces $3 Billion Share Repurchase Program
PR
11/12Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of..
CI
11/12Regeneron Secures European Commission Approval for Antibody Cocktail to Treat, Prevent ..
MT
11/12European Commission Grants Marketing Authorization For Roche's COVID-19 Antibody Cockta..
MT
11/12Regeneron Antibody Cocktail Approved by European Commission to Treat and Prevent COVID-..
PR
11/12EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
RE
11/12GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion
RE
11/12Regeneron Pharmaceuticals, Inc. authorizes a Buyback Plan.
CI
11/11EU Drug Regulator Backs COVID-19 Therapy from South Korea's Celltrion
MT
11/11Roche, Regeneron's COVID-19 Antibody Cocktail Gets European Medicines Agency's Recommen..
MT
11/11Regeneron Gets CHMP Backing for Covid-19 Cocktail
DJ
11/11Regeneron Pharmaceuticals Gets Recommendation for EU Approval of COVID-19 Antibody Cock..
MT
11/11European Medicines Agency Recommends Ronapreve, Regkirona Covid-19 Treatments for Appro..
DJ
11/11CHMP Recommends EU Approval of Regeneron Antibody Cocktail to Treat and Prevent COVID-1..
PR
11/11European Medicines Agency's Committee for Medicinal Products for Human Use Recommends A..
CI
11/09Regeneron Pharmaceuticals - NEW PHASE 3 ANALYSES SHOW THAT A SINGLE DOSE OF REGEN-COV (..
AQ
11/09EU Poised To Approve Two COVID-19 Antibody Drugs
MT
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/08Health Care Climbs On Sales Expectations -- Health Care Roundup
DJ
11/08Regeneron Study Shows COVID-19 Drug Cocktail Almost 82% Effective in Preventing Infecti..
MT
11/08Regeneron says antiviral COVID-19 cocktail shows protection after 8 months
AQ
11/08Regeneron Says Regen-Cov Antibody Cocktail Reduces Risk of Contracting COVID-19 by 81.6..
MT
11/08Regeneron Pharmaceuticals's COVID-19 Drug Reduces Infection Risk by 82% in Late-Stage S..
MT
11/08Regeneron's antibody drug shows protection against COVID-19 for up to 8 months
RE
11/08Regeneron's antibody therapy shows long-term protection against COVID-19
RE
11/08Regeneron Pharmaceuticals, Inc. Announces New Phase 3 Analyses Shows Single Dose of Reg..
CI
11/05Regeneron Pharmaceuticals Files Shelf Registration Statement For Potential Security Off..
MT
11/05Pfizer COVID-19 pill data slams competitors' shares, shakes up healthcare sector
RE
11/05HC Wainwright Adjusts Price Target on Regeneron Pharmaceuticals to $844 From $842, Main..
MT
11/05UBS Adjusts Price Target on Regeneron Pharmaceuticals to $770 From $763, Maintains Buy ..
MT
1  2  3  4  5  6  7  8  9  10Next